Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.06.19.158071
Publication URI: http://dx.doi.org/10.1101/2020.06.19.158071
Type: Preprint